NCT01052090View on ClinicalTrials.gov

Safety and Efficacy Study in Hepatitis C Patients With PHN121

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Hepatitis C Virus Infection
Interventions
DRUG

PHN121

a size 0 hard gel capsule containing 323.6 mg active ingredient, a complex mixture prepared from 5 commonly practiced botanical traditional Chinese medicines

Trial Locations (2)

Unknown

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

PhytoHealth, Taipei

Sponsors
All Listed Sponsors
lead

PhytoHealth Corporation

INDUSTRY